Estimation of breast height diameter and trunk curvature with linear and single-photon LiDARs

International audienceContext: Precision forestry together with new sensor technologies implies Digital Forest Inventories for estimation of volume and quality of trees in a stand.Aims: This study compared commercial LiDAR, new prototype SPAD LiDAR, and manual methods for measuring tree quality attributes, i.e., diameter at breast height (DBH) and trunk curvature in the forest stand.Methods: We measured 7 Scots pine trees (Pinus sylvestris) with commercial LiDAR (Zeb Horizon by GeoSLAM), prototype SPAD LiDAR, and manual devices. We compared manual measurements to the DBH and curvature values estimated based on LiDAR data. We also scanned a densely branched Picea abies to compare penetrability of the LiDARs and detectability of the obstructed trunk.Results: The DBH values deviated 1–3 cm correlating to the specified accuracies of the employed devices, showing close to acceptable results. The curvature values deviated 1–6 cm implying distorted range measurements from the top part of the trunks and inaccurate manual measurement method, leaving space for improvement. The most important finding was that the SPAD LiDAR outperformed conventional LiDAR in detecting tree stem of the densely branched spruce.Conclusion: These results represent preliminary but clear evidence that LiDAR technologies are already close to acceptable level in DBH measurements, but not yet satisfactory for curvature measurements. In addition, terrestrial SPAD LiDAR has a great potential to outperform conventional LiDARs in forest measurements of densely branched trees

Early non-invasive cardiac output monitoring in hemodynamically unstable intensive care patients: A multi-center randomized controlled trial

Introduction Acute hemodynamic instability increases morbidity and mortality. We investigated whether early non-invasive cardiac output monitoring enhances hemodynamic stabilization and improves outcome. Methods A multicenter, randomized controlled trial was conducted in three European university hospital intensive care units in 2006 and 2007. A total of 388 hemodynamically unstable patients identified during their first six hours in the intensive care unit (ICU) were randomized to receive either non-invasive cardiac output monitoring for 24 hrs (minimally invasive cardiac output/MICO group; n = 201) or usual care (control group; n = 187). The main outcome measure was the proportion of patients achieving hemodynamic stability within six hours of starting the study. Results The number of hemodynamic instability criteria at baseline (MICO group mean 2.0 (SD 1.0), control group 1.8 (1.0); P = .06) and severity of illness (SAPS II score; MICO group 48 (18), control group 48 (15); P = .86)) were similar. At 6 hrs, 45 patients (22%) in the MICO group and 52 patients (28%) in the control group were hemodynamically stable (mean difference 5%; 95% confidence interval of the difference -3 to 14%; P = .24). Hemodynamic support with fluids and vasoactive drugs, and pulmonary artery catheter use (MICO group: 19%, control group: 26%; P = .11) were similar in the two groups. The median length of ICU stay was 2.0 (interquartile range 1.2 to 4.6) days in the MICO group and 2.5 (1.1 to 5.0) days in the control group (P = .38). The hospital mortality was 26% in the MICO group and 21% in the control group (P = .34). Conclusions Minimally-invasive cardiac output monitoring added to usual care does not facilitate early hemodynamic stabilization in the ICU, nor does it alter the hemodynamic support or outcome. Our results emphasize the need to evaluate technologies used to measure stroke volume and cardiac output--especially their impact on the process of care--before any large-scale outcome studies are attempted